Cargando…

Comparing symptomatic and screen-detected breast cancer.

Detalles Bibliográficos
Autores principales:	Evans, A. J., De Nunzio, M., Davidson, I. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034127/ https://www.ncbi.nlm.nih.gov/pubmed/7599062

Ejemplares similares

Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital
por: Fujiwara, Yu, et al.
Publicado: (2020)

Explaining the difference in prognosis between screen-detected and symptomatic breast cancers
por: Allgood, P C, et al.
Publicado: (2011)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

The influence on survival of delay in the treatment initiation of screening detected non-symptomatic breast cancer
por: Li, Yan, et al.
Publicado: (2019)

Comparison of outcome data for screen-detected and symptomatic breast cancers diagnosed in the West Midlands region in 2002
por: Lagord, C, et al.
Publicado: (2006)

Anatomical association of fluid yielding ducts with location of the breast cancer affected segment in screen detected and symptomatic breast cancer
por: Gui, GPH, et al.
Publicado: (2009)

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?
por: Wishart, G C, et al.
Publicado: (2008)

Season of detection of breast cancer.
por: Mason, B., et al.
Publicado: (1991)

Comparison of prognostic indices in symptomatic and screen-detected invasive breast cancer in Asian and Caucasian women
por: Steele, Andrew, et al.
Publicado: (2015)

Season of initial detection in breast cancer.
por: Galea, M. H., et al.
Publicado: (1991)

Appearances of screen-detected versus symptomatic colorectal cancers at CT colonography
por: Plumb, Andrew A., et al.
Publicado: (2016)

Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK
por: Brentnall, A R, et al.
Publicado: (2014)

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series
por: Crispo, Anna, et al.
Publicado: (2013)

Promoting early symptomatic presentation in older women with breast cancer in the NHS breast screening programme
por: Forbes, LJL, et al.
Publicado: (2010)

Influences of Electrostatic or Triboelectric Charges and Breast Implant Symptomatic Contamination
por: Peña-Cabús, Guillermo
Publicado: (2017)

Stages of screen-detected breast cancer
por: Koufopoulos, K, et al.
Publicado: (2000)

Symptomatic splenoma in a child
por: Shah, Parveen, et al.
Publicado: (2009)

St Gallen molecular subtypes in screening‐detected and symptomatic breast cancer in a prospective cohort with long‐term follow‐up
por: Falck, A. K., et al.
Publicado: (2016)

Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers
por: Niraula, Saroj, et al.
Publicado: (2020)

The influence on survival of delay in the presentation and treatment of symptomatic breast cancer
por: Richards, M A, et al.
Publicado: (1999)

Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening.
por: Cowan, W. K., et al.
Publicado: (1991)

Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022)

Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer
por: Titan, Ashley L., et al.
Publicado: (2022)

Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
por: Moshina, Nataliia, et al.
Publicado: (2021)

Role of mammogram and ultrasound imaging in predicting breast cancer subtypes in screening and symptomatic patients
por: Ian, Tay Wei Ming, et al.
Publicado: (2021)

Estimation of lead time and overdiagnosis in breast cancer screening
por: Gøtzsche, P C, et al.
Publicado: (2009)

Mutation screening of RAD51C in male breast cancer patients
por: Silvestri, Valentina, et al.
Publicado: (2011)

PB.42. Influences upon presentation to the symptomatic breast clinic: is there an increase in symptomatic referrals due to the physical presence of the breast screening van within an area?
por: Wotton, F, et al.
Publicado: (2014)

A model of the natural history of screen-detected prostate cancer
por: Metcalfe, C, et al.
Publicado: (2006)

The Importance of Symptomatic or Asymptomatic Transcatheter Heart Valve Thrombosis
por: Seropian, Ignacio M.
Publicado: (2021)

Breast screening interval and the characteristics of screen-detected cancers
por: Tupper, Carl A, et al.
Publicado: (2015)

Pain Management During Uterine Artery Embolization for Symptomatic Uterine Fibroids
por: Lampmann, L. E., et al.
Publicado: (2007)

Current Management of Symptomatic Pericardial Effusions in Cancer Patients
por: Besnard, Audrey, et al.
Publicado: (2019)

The detectability of breast cancer by screening mammography.
por: Ciatto, S., et al.
Publicado: (1995)

Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021
por: Shusted, Christine S., et al.
Publicado: (2022)

Symptomatic primary hyperparathyroidism in Indians
por: Kamalanathan, Sadishkumar C., et al.
Publicado: (2011)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Prognosis of small screen-detected invasive breast cancers
por: Ellis, I
Publicado: (2008)

Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations
por: Polage, Christopher R., et al.
Publicado: (2020)

The importance of early detection of calcifications associated with breast cancer in screening
por: Mordang, J. J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9g6eugs16tsrkvepp14665uc9s